Japan Ranks 24th In International Clinical Trials
This article was originally published in PharmAsia News
Japan ranks 24th worldwide in the number of international clinical trials it carries out to test the efficacy and safety of new drugs, according to a survey by the Office of Pharmaceutical Industry Research.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.